Proteon logo     Print Page | Close Window

SEC Filings

4
DEERFIELD MANAGEMENT CO filed this Form 4 on 08/04/2017
Entire Document
 

 

Joint Filer Information

 

Names: Deerfield Management Company, L.P.
   
Address:

780 Third Avenue, 37th Floor

New York, NY  10017

   
Designated Filer: James E. Flynn
   
Issuer and Ticker Symbol: Proteon Therapeutics, Inc.  [PRTO]
   
Date of Event Requiring Statement:  August 2, 2017

 

The undersigned, Deerfield Management Company, L.P., is jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Proteon Therapeutics, Inc.

 

Signatures:

 

DEERFIELD MANAGEMENT COMPANY, L.P.

 

By:  Flynn Management LLC, General Partner

 

By: /s/ Jonathan Isler

       Jonathan Isler, Attorney-In-Fact